Scott Thomas Jackson
Director · 2 filings · Latest: Jun 23, 2026
MACROGENICS INC
Spero Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MGNX | Scott Thomas Jackson | Director | May 18, 2026 | Option Exercise | — | 3,750 | — | 14,750 |